Skip to main content
Professional Technical IVT

well-differentiated neuroendocrine tumor

Low to intermediate-grade neuroendocrine tumor maintaining organized cellular architecture and expressing neuroendocrine markers.

Full Definition

Well-differentiated neuroendocrine tumor represents a category of neuroendocrine neoplasms characterized by organized histological architecture that resembles normal neuroendocrine tissue, with cells arranged in nests, ribbons, or trabecular patterns. These tumors maintain expression of neuroendocrine markers such as chromogranin A and synaptophysin, and have relatively low proliferative activity (Ki-67 typically ≤20% and mitotic count ≤20 per 2 mm²). Well-differentiated neuroendocrine tumors correspond to WHO Grades 1 and 2, generally have better prognosis than poorly differentiated neuroendocrine carcinomas, and may be amenable to somatostatin analog therapy. The term reflects both morphological characteristics and biological behavior, distinguishing these tumors from high-grade neuroendocrine carcinomas.

Usage

Usage note: Hyphenate 'well-differentiated' when used as compound modifier; contrast with poorly differentiated types.

In Context

  • "Histology revealed a well-differentiated neuroendocrine tumor with Ki-67 index of 5% and low mitotic count." — Pathology report
  • "The patient's well-differentiated neuroendocrine tumor showed excellent response to octreotide therapy." — Clinical follow-up

Also known as

WDNET low-grade neuroendocrine tumor

Contrasted with

poorly differentiated neuroendocrine carcinoma

Don't confuse with

moderately differentiated NET neuroendocrine carcinoma

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON